1. Home
  2. DRTS vs LYNX Comparison

DRTS vs LYNX Comparison

Compare DRTS & LYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

SELL

Current Price

$13.21

Market Cap

1.4B

Sector

Health Care

ML Signal

SELL

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$11.31

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
DRTS
LYNX
Founded
2015
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
DRTS
LYNX
Price
$13.21
$11.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$17.80
★ $19.67
AVG Volume (30 Days)
432.5K
★ 437.1K
Earning Date
11-19-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$35.28
Revenue Next Year
$1,235.59
$34.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$10.70
52 Week High
$15.79
$14.64

Technical Indicators

Market Signals
Indicator
DRTS
LYNX
Relative Strength Index (RSI) 35.13 37.38
Support Level $11.51 N/A
Resistance Level $14.00 $13.74
Average True Range (ATR) 0.51 0.68
MACD -0.19 -0.12
Stochastic Oscillator 5.18 29.32

Price Performance

Historical Comparison
DRTS
LYNX

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

Share on Social Networks: